Telerehabilitation and Occupational Performance in Stroke

NCT07389811 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-02-05

No results posted yet for this study

Summary

The objective of this randomized clinical trial is to evaluate the effects of using telerehabilitation (remote care) by occupational therapists on improving the performance and recovery of patients within the Brazilian Unified Health System (SUS) who have suffered a stroke and are on a waiting list for specialized rehabilitation care.

The main question it seeks to answer is:

* What are the effects of occupational therapy services provided through telerehabilitation for the population with stroke sequelae?
* Do the guidelines provided by telerehabilitation result in improved occupational performance (ability to perform activities of daily living) of the participants?

The researchers compare an experimental group (receiving telerehabilitation treatment) with a waitlist group (which will remain on the waitlist without receiving a specific intervention).

Participants are required to:

* Answer a sociodemographic questionnaire;
* Participate in assessments using standardized scales on basic and instrumental activities of daily living and use of the affected limb (Instrumental Activities of Daily Living Scale, Katz Scale, and Motor Activity Log).
* Receive and apply Occupational Therapy guidelines (if in the intervention group).

Conditions

Interventions

BEHAVIORAL

Telerehabilitation in Occupational Therapy

Online guidance sessions for post-stroke patients and their caregivers, aimed at improving occupational performance, using standardized scales.

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-27
Primary Completion
2025-12-05
Completion
2025-12-26

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07389811 on ClinicalTrials.gov